Professional Documents
Culture Documents
Yunita Asri P
G99141034
Syifa Marhattya R
G99141035
Pembimbing:
Ganung Harsono, dr, Sp.A(K)
Abstract
Abstract
Introduction
Introduction
Epidemiolog
y
CLINICAL
PRESENTATION
DIAGNOSTIC
PROCEDURES
Treatment
Epidemiolog
y
CLINICAL
PRESENTATION
DIAGNOSTIC
PROCEDURES
Treatment
Epidemiolog
y
CLINICAL
PRESENTATION
DIAGNOSTIC
PROCEDURES
Treatment
Epidemiolog
y
CLINICAL
PRESENTATION
DIAGNOSTIC
PROCEDURES
Treatment
Epidemiolog
y
CLINICAL
PRESENTATION
DIAGNOSTIC
PROCEDURES
Treatment
Epidemiolog
y
CLINICAL
PRESENTATION
DIAGNOSTIC
PROCEDURES
Treatment
2.
2. Atopy
Atopy Patch
Patch Test,
Test, Total
Total IgE,
IgE, and
and Intradermal
Intradermal Tests
Tests
there is no agreement on standardization on
the preparation and application of antigen.
reading the test is difficult and remains subjective
Intradermal testing should not be performed
because it carries a risk of systemic allergic reaction
in highly sensitized individuals
3.
3. Specic
Specic IgG
IgG Antibodies
Antibodies and
and Other
Other Nonstandardized
Nonstandardized or
or
Unproven
Unproven Tests
Tests and
and Procedures
Procedures
Epidemiolog
y
CLINICAL
PRESENTATION
DIAGNOSTIC
PROCEDURES
used in research
protocols, but not
in clinical practice
Treatment
Epidemiolog
y
CLINICAL
PRESENTATION
DIAGNOSTIC
PROCEDURES
Treatment
4.
4. Endoscopy
Endoscopy and
and Histology
Histology
Diagnostic
Diagnostic Elimination
Elimination of
of CMP
CMP
Epidemiolog
y
CLINICAL
PRESENTATION
DIAGNOSTIC
PROCEDURES
Treatment
Infants with signicant gastrointestinal symptoms with no
improvement using a hydrolyzed or a soy formula may benet from a
further period of observation on an amino acidbased formula (AAF)
before CMPA is excluded. This is particularly true in patients with multiple
sensitizations
Epidemiolog
y
CLINICAL
PRESENTATION
DIAGNOSTIC
PROCEDURES
Treatment
Oral
Oral Food
Food Challenge
Challenge Procedure
Procedure with
with CMP
CMP
Epidemiolog
y
CLINICAL
PRESENTATION
DIAGNOSTIC
PROCEDURES
Treatment
Oral
Oral Food
Food Challenge
Challenge Procedure
Procedure with
with CMP
CMP
Epidemiolog
y
CLINICAL
PRESENTATION
DIAGNOSTIC
PROCEDURES
Treatment
Epidemiolog
y
CLINICAL
PRESENTATION
DIAGNOSTIC
PROCEDURES
Treatment
Epidemiolog
y
CLINICAL
PRESENTATION
DIAGNOSTIC
PROCEDURES
Treatment
Epidemiolog
y
CLINICAL
PRESENTATION
DIAGNOSTIC
PROCEDURES
Treatment
Epidemiolog
y
CLINICAL
PRESENTATION
DIAGNOSTIC
PROCEDURES
Treatment
Reevaluation
Reevaluation
Epidemiolog
y
CLINICAL
PRESENTATION
DIAGNOSTIC
PROCEDURES
Treatment
Prognosis
Prognosis
Epidemiolog
y
CLINICAL
PRESENTATION
DIAGNOSTIC
PROCEDURES
Treatment
Approximately 50% of
affected children develop
tolerance by the age of 1
year,>75% by the age of
3 years, and>90% are
tolerant at 6 years of age
Thank You!